Policy debates typically return to scheduling and bans. India and the United States both of those deal with versions of a similar concern: no matter whether to impose broader, course-extensive controls more than fentanyl analogs as well as their precursors, or to help keep compound-by-compound scheduling that will lag driving traffickers’ innovat